Johannes H. Schulte

Berlin, BE 13353, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 207 publications

Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort.

Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort.

Journal: Journal for immunotherapy of cancer

Published: April 20, 2026

European expert recommendations for comprehensive pre-treatment, treatment-phase and post-treatment care of patients with metachromatic leukodystrophy treated with autologous haematopoietic stem and progenitor cell gene therapy.

European expert recommendations for comprehensive pre-treatment, treatment-phase and post-treatment care of patients with metachromatic leukodystrophy treated with autologous haematopoietic stem and progenitor cell gene therapy.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Published: March 25, 2026

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.

Journal: The Journal of clinical investigation

Published: February 12, 2026

Police field trial and exploratory laboratory optimization of the DNA-Buster.

Police field trial and exploratory laboratory optimization of the DNA-Buster.

Journal: Science & justice : journal of the Forensic Science Society

Published: February 04, 2026

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

Journal: Bone marrow transplantation

Published: January 18, 2026

ALK Inhibition Prolongs Survival in a Mouse Model of ALK-Positive Anaplastic Thyroid Cancer.

ALK Inhibition Prolongs Survival in a Mouse Model of ALK-Positive Anaplastic Thyroid Cancer.

Journal: Thyroid : official journal of the American Thyroid Association

Published: December 30, 2025

Current treatment strategies for first relapse of high-risk neuroblastoma.

Current treatment strategies for first relapse of high-risk neuroblastoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 16, 2025

YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.

YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.

Journal: Cancers

Published: December 10, 2025

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Journal: Cancer research

Published: November 19, 2025

Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b study.

Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b study.

Journal: Antimicrobial agents and chemotherapy

Published: August 18, 2025

Investigating genetic modifications to enhance L1CAM-CAR T cell migration in solid tumors in a 3D bioprinted neuroblastoma model.

Investigating genetic modifications to enhance L1CAM-CAR T cell migration in solid tumors in a 3D bioprinted neuroblastoma model.

Journal: Frontiers in immunology

Published: July 31, 2025

Correction: GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025.

Correction: GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025.

Journal: Klinische Padiatrie

Published: June 05, 2025

Showing 1-12 of 207

Last Updated: 09/26/2026